Brief: Inozyme Pharma Reports Full Year 2022 Financial Results And Provides Business Highlights

Inozyme Pharma

22/03/2023 12:55

March 22 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS FULL YEAR 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS HIGHLIGHTS
    * INOZYME PHARMA INC FY LOSS PER SHARE $1.78
    * INOZYME PHARMA INC - CURRENT CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS ANTICIPATED TO FUND CASH FLOW REQUIREMENT
INTO Q4 OF 2024
    * INOZYME PHARMA INC - FOUNDING CEO, AXEL BOLTE TO RETIRE
    * INOZYME PHARMA INC -  DOUGLAS A. TRECO TO SUCCEED BOLTE AS
CEO

Source text for Eikon:  ID:nGNXc7HKwd 
Further company coverage:  INZY.O 

 ((Reuters.Briefs@thomsonreuters.com;;))